Latest Breaking News On - Alexandre lebeautadded - Page 1 : comparemela.com

Regulatory News: OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) (Paris:OSE) today announced the appointment by cooptation of Alexandre Lebeaut as an independent Director of the Company . Alexandre

United statesFrance generalAlexandre lebeautGuillaume van renterghem lifesciThomas guillotAlexis peyrolesDominique costantiniAlexandre lebeautaddedFlorence portejoieDarren oplandNantes university hospitalChildren institute for advanced clinical trialsUniversity of paris descartesBoehringer ingelheimRemuneration committeeLifesci communications